Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Press Releases

Immer mehr HPV-bedingte Fälle von Rachenkrebs durch Oralsex

SWR Wissen        4. Mai 2023

Auch wenn die Gesamtzahl der Neuerkrankungen gering ist: Immer mehr Menschen in Deutschland erkranken infolge einer HPV-Infektion an Rachenkrebs. Übertragen wird das humane Pampillomvirus – kurz HPV – zum Beispiel durch Oralsex. Manche Forschende reden sogar von einer Epidemie. Fast jeder steckt sich in seinem Leben einmal an, meist schon bei den ersten sexuellen Erfahrungen. More...

First successful trial for early detection of HPV-related cancer of the pharynx

DKFZ News        28. September 2022

Screening trials for the early detection of rare diseases often fail due to insufficient predictive power of the results. For the rare HPV-related cancer of the pharynx, scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) now relied on the combined detection of antibodies against two different viral proteins in a proof-of concept trial. This enabled them to significantly improve the positive predictive value of the test results. More...

Human Papilloma Viruses: Antibody Status as a Cancer Warning

DKFZ News        13. October 2020

Human papilloma viruses (HPV) can cause various tumor diseases, including cancer of the throat. Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg are now providing evidence that antibodies against certain viral proteins could be an early warning sign of an increased risk of developing throat cancer. More...

Mit Hochdurchsatz gegen Krebs und COVID-19: Dieter Morszeck Stiftung unterstützt Deutsches Krebsforschungszentrum mit einer Million Euro

DKFZ News        18. May 2020

Mit einer Million Euro fördert die Dieter Morszeck Stiftung am Deutschen Krebsforschungszentrum (DKFZ) den Aufbau einer Hochdurchsatz-Infrastruktur für die serologische Analyse an Blutproben. Die Technologie ermöglicht es, große Personengruppen auf akute oder frühere Infektionen mit Viren oder Bakterien zu untersuchen. Zunächst soll die Plattform eingesetzt werden, um den Nachweis von Antikörpern gegen SARS-CoV-2 und gleichzeitig andere Corona-Viren in großem Maßstab zu ermöglichen. Langfristig soll die Methodik genutzt werden, um zu untersuchen, in wie weit bestimmte Viren und Bakterien mitverantwortlich für die Entstehung von Krebsarten sind. More...

A biomarker for cancer of the oropharynx

DKFZ News        3. April 2017

A growing number of cases of oropharyngeal cancer are considered to be a consequence of infection with human papillomaviruses (HPV). Scientists at the German Cancer Research Center (DKFZ) have now revealed that a single blood sample test for specific antibodies can identify persons who are at a high risk of developing this type of cancer ten years or more before cancer diagnosis. More ...

to top
powered by webEdition CMS